Li G, Silverman J M, Altstiel L D, Haroutunian V, Perl D P, Purohit D, Birstein S, Lantz M, Mohs R C, Davis K L
Psychiatry Service, Bronx VA Medical Center, NY 10468, USA.
Genet Epidemiol. 1996;13(3):285-98. doi: 10.1002/(SICI)1098-2272(1996)13:3<285::AID-GEPI5>3.0.CO;2-5.
Recent studies have found an association between presence of apolipoprotein E (APOE) epsilon 4 allele and Alzheimer's disease (AD). The present study compared the cumulative risk of primary progressive dementia (PPD) in relatives of AD probands carrying at least one copy of the epsilon 4 allele with the relatives of AD probands not carrying epsilon 4 and with relatives of non-demented controls. Our aim was to determine whether the familial aggregation of PPD in relatives of AD probands is primarily due to those carrying epsilon 4. Seventy-seven neuropathologically diagnosed AD patients were obtained as probands through our Alzheimer's Disease Research Center Brain Bank. AD probands were genotyped for APOE. As a comparison group, 198 non-demented probands were also included. Through family informants, demographic and diagnostic data were collected on 382 first-degree relatives (age > or = 45 years) of AD probands and 848 relatives of the controls. We found that the cumulative risk of PPD in both relatives of AD probands with and without the epsilon 4 allele was significantly higher than that in the relatives of non-demented controls. However, the increased risk in the relatives of AD probands with the epsilon 4 allele was marginally, but not significantly, lower than the risk in the relatives of probands without epsilon 4. A greater likelihood of death by heart diseases over developing PPD in relatives of AD probands with epsilon 4 (3.1-fold increase) was found compared to relatives of probands without epsilon 4 (1.7-fold increase), especially prior to age 70, although the difference was not statistically significant. The increased familial risk for PPD in the relatives of AD probands with the APOE-epsilon 4 allele relative to controls suggests that familial factors in addition to APOE-epsilon 4 are risk factors for AD. Differential censorship from increased mortality of heart diseases may have prevented a higher incidence of PPD among the relatives of probands with epsilon 4.
最近的研究发现载脂蛋白E(APOE)ε4等位基因的存在与阿尔茨海默病(AD)之间存在关联。本研究比较了携带至少一份ε4等位基因的AD先证者亲属、不携带ε4的AD先证者亲属以及非痴呆对照者亲属发生原发性进行性痴呆(PPD)的累积风险。我们的目的是确定AD先证者亲属中PPD的家族聚集是否主要归因于携带ε4的那些人。通过我们的阿尔茨海默病研究中心脑库获得了77例经神经病理学诊断的AD患者作为先证者。对AD先证者进行APOE基因分型。作为对照组,还纳入了(198)例非痴呆先证者。通过家族 informant,收集了(382)名AD先证者的一级亲属(年龄≥45岁)和(848)名对照者亲属的人口统计学和诊断数据。我们发现,携带和不携带ε4等位基因的AD先证者亲属中PPD的累积风险均显著高于非痴呆对照者亲属。然而,携带ε4等位基因的AD先证者亲属中增加的风险略低于不携带ε4的先证者亲属中的风险,但差异不显著。与不携带ε4的先证者亲属(增加(1.7)倍)相比,携带ε4的AD先证者亲属死于心脏病的可能性高于发生PPD的可能性(增加(3.1)倍),尤其是在70岁之前,尽管差异无统计学意义。相对于对照组,携带APOE-ε4等位基因的AD先证者亲属中PPD家族风险增加表明,除了APOE-ε4之外的家族因素也是AD的风险因素。心脏病死亡率增加导致的差异删失可能阻止了携带ε4的先证者亲属中PPD发病率更高。